^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Anal Carcinoma |
| Regimen: | FOLFCIS (5-fluorouracil + cisplatin + leucovorin calcium) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
06/05/2020
Excerpt:
Other recommended treatment options include 5-FU, leucovorin, and cisplatin (FOLFCIS) or 5-FU, leucovorin, and oxaliplatin (FOLFOX).
